01 March 1999
Evaluation of renal and auditory functions in children, in relation to the dosage regimen (once- daily versus multiple-daily) of amikacin
Maria Gołębiowska, Jarosław Wlazłowski, Jarosław AndrzejewskiMed Sci Monit 1999; 5(2): CR280-284 :: ID: 505134
Abstract
The aim of this study was to evaluate side effects of amikacin administration in the treatment of infants and small children, in relation to its dosage. The study group comprised 49 children aged between 2 months and 3 years, who received amikacin due to severe infections - once (21), or twice (three times) a day (28 children). We performed urinalysis as well as serum urea, creatinine and endogenous creatinine clearance levels in each patient before and following treatment completion (Schwartz method). Moreover, we assessed the urine concentration of β2 microglobulin in 30 children (14 from group A and 16 from group B). Hearing was evaluated in 31 patients, including 15 from group A and 16 from group B, by means of subjective testing methods (ABR, SOAE, TOAE). Renal function compromise defined as an increase of serum creatinine by more than 44.2 µl/L compared with primary values was not observed in any of the children. The concentration of β2 microglobulin was significantly higher before treatment and decreased during the course of treatment regardless of amikacin dosage. We noted heavy bilateral hearing impairment in one child. The patient had received aminoglycosides once a day. Due to the coexistence of various risk factors it was impossible to establish whether the hearing impairment was a result of aminoglycoside activity on internal ear cells. In conclusion, the administration of amikacin once a day does not increase the risk of side effects.
Keywords: ototoxicity, nephrotoxicity, dosage, children, amikacin
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952